Senti Biosciences, Inc. (SNTI)

NASDAQ: SNTI · Real-Time Price · USD

0.9001

-0.0799 (-8.15%)

At close: Feb 4, 2026, 4:00 PM EST

0.8821

-0.0180 (-2.00%)

Pre-market: Feb 5, 2026, 8:30 AM EST

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Next-generation Cell and Gene Therapies	2.56M
Next-generation Cell and Gene Therapies Growth	-40.25%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
United States	2.56M
United States Growth	-40.25%